Early efficacy signal demonstrated in advanced melanoma in a phase I trial of the oncogenic BRAF-selective inhibitor PLX4032 Meeting Abstract


Authors: Chapman, P.; Puzanov, I.; Sosman, J.; Kim, K.; Ribas, A.; McArthur, G.; Lee, R.; Grippo, J.; Nolop, K.; Flaherty, K.
Abstract Title: Early efficacy signal demonstrated in advanced melanoma in a phase I trial of the oncogenic BRAF-selective inhibitor PLX4032
Meeting Title: 15th ECCO - 34th ESMO Multidisciplinary Cancer Congress
Journal Title: EJC Supplements
Volume: 7
Issue: 3
Meeting Dates: 2009 Sep 20-24
Meeting Location: Berlin, Germany
ISSN: 1359-6349
Publisher: Pergamon-Elsevier Science Ltd  
Date Published: 2009-09-01
Start Page: 5
Language: English
ACCESSION: ISI:000270645000015
PROVIDER: wos
DOI: 10.1016/S1359-6349(09)72035-X
Notes: Meeting Abstract: 6BA - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Chapman
    326 Chapman